Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition-Reference-Cited by-全球学者库

Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibition

Published:2017-03-24 Issue:5 Volume:177 Page:726-740
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Liu Chun-Yu¹²³⁴,Hsieh Feng-Shu⁵,Chu Pei-Yi⁶⁷,Tsai Wen-Chun²,Huang Chun-Teng³⁸,Yu Yuan-Bin³⁴,Huang Tzu-Ting¹²,Ko Po-Shen²³⁴,Hung Man-Hsin²³⁴,Wang Wan-Lun²,Shiau Chung-Wai⁹,Chen Kuen-Feng⁵¹⁰^ORCID

Affiliation:

1. Comprehensive Breast Health Centre; Taipei Veterans General Hospital; Taipei Taiwan

2. Division of Medical Oncology; Department of Oncology; Taipei Veterans General Hospital; Taipei Taiwan

3. School of Medicine; National Yang-Ming University; Taipei Taiwan

4. Division of Haematology and Oncology; Department of Medicine; Taipei Veterans General Hospital; Taipei Taiwan

5. Department of Medical Research; National Taiwan University Hospital; Taipei Taiwan

6. Department of Pathology; Show Chwan Memorial Hospital; Changhua Taiwan

7. School of Medicine; Fu Jen Catholic University; New Taipei City Taiwan

8. Division of Haematology and Oncology; Department of Medicine; Yang-Ming Branch of Taipei City Hospital; Taipei Taiwan

9. Institute of Biopharmaceutical Sciences; National Yang-Ming University; Taipei Taiwan

10. National Center of Excellence for Clinical Trial and Research; National Taiwan University Hospital; Taipei Taiwan

Funder

Yen Tjing Ling Medical Foundation

Ministry of Science and Technology, Taiwan

Yang-Ming Branch of Taipei City Hospital

Taipei Veterans General Hospital

TVGH-NTUH Joint Research Program

National Taiwan University Hospital

Chong Hin Loon Memorial Cancer

Biotherapy Research Centre of National Yang-Ming University, Taipei, Taiwan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14620/fullpdf

Reference52 articles.

1. CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia;Barragan;Haematologica,2015

2. Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy;Berenson;Leukemia,2014

3. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics;Bialojan;The Biochemical Journal,1988

4. Prognostic role of CIP2A expression in serous ovarian cancer;Bockelman;British Journal of Cancer,2011

5. CIP2A overexpression is associated with MYC expression in colorectal cancer;Bockelman;Cancer Biology & Therapy,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma;Chemical Biology & Drug Design;2023-10-06

2. From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer;Frontiers in Genetics;2023-02-24

3. Prodigiosin inhibits the proliferation of glioblastoma by regulating the KIAA1524/PP2A signaling pathway;Scientific Reports;2022-11-02

4. Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis;Cancers;2021-09-28

5. Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System;Biomolecules;2021-09-10